Physicians may choose to prescribe generic injectable semaglutide for off-label oral use or utilize generic versions in compounding, potentially undermining the premium price of the still-patented oral formulation
When this hormone binds to receptors in the brain, pancreas, stomach, and elsewhere, several things happen: Appetite is significantly reduced, with many patients reporting a dramatic decrease in food cravings Gastric emptying slows, meaning food stays in the stomach longer and fullness is sustained after smaller meals Blood sugar regulation improves, reducing the energy spikes and dips that typically drive overeating Interest in high-calorie and highly processed foods often reduces, an effect many patients describe as the food noise quietening Mounjaro (tirzepatide) adds a second mechanism by also activating the GIP receptor
GaoZYinJZhangJWardREMartinRJLefevreMet al
United Healthcare, Cigna, Blue Cross Blue Shield, Aetna, and others may cover semaglutide treatments depending on individual plans
A related and often overlooked factor is a reduction in non-exercise activity thermogenesis (NEAT) the energy used in everyday movements such as fidgeting, standing, and walking
